Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 17 min ago
Peer-reviewedCC BY-NC-NDEndocrine Journal

Intracrine androgen metabolism in the meibomian gland: regulation, circadian control, and implications in dry eye disease

Abstract

The meibomian glands play a central role in maintaining ocular surface homeostasis by producing meibum, which is the lipid layer of the tear film that suppresses tear evaporation. Dysregulation of the secretion of this lipid leads to meibomian gland dysfunction (MGD), the most common cause of evaporative dry eye disease. Accumulating evidence indicates that androgen signaling is a critical regulator of meibomian gland structure and function. In contrast to classical endocrine mechanisms, androgen action in this tissue is largely mediated by intracrine steroid metabolism, whereby circulating adrenal precursors are locally converted to active androgens within the gland. Key steroidogenic enzymes, including 3β-hydroxysteroid dehydrogenase (3β-HSD), are expressed in the meibomian acinar cells, thereby enabling local testosterone production. Simultaneously, the gland exhibits robust metabolic pathways that convert testosterone to downstream androstane derivatives, providing a mechanism for the spatially restricted control of androgen signaling. Recent study has revealed that the intracrine steroidogenic system is affected by circadian rhythms. In particular, 3β-HSD activity exhibits daily rhythmicity that parallels fluctuations in nicotinamide adenine dinucleotide (NAD+), suggesting that NAD+-dependent metabolic processes contribute to temporal control of local androgen production. Importantly, administration of NAD+ precursors improves meibomian gland morphology in experimental models of aging-associated MGD. This review summarizes the current knowledge on intracrine androgen metabolism in the meibomian gland and highlights emerging metabolic and circadian mechanisms that may provide novel therapeutic targets for dry eye disease.

Related

  1. Tryptophan metabolism circadian regulation: clinical and pharmacological implications
    Consuelo Fabi, Sarah Balucchi, Marina Maria Bellet
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPhysiologyCrossrefPMC
  2. Meibomian gland epithelial cells demonstrate enhanced reliance on glycolysis for energy metabolism and differentiation
    Yaoyao Ren, Wenjing Li, Yuan Zhang +7
    Eye and VisionPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  3. Effects of Maternal Caffeine Exposure During Gestation on Neurobehavior, Glucose Metabolism and Circadian Rhythm in Offspring Rats
    Minying Sun, Huanxin Pan, Guangyu Yang +4
    ToxicsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Timed secreted proteomes reveal regulation of hepatokines by the liver circadian clock
    Christopher Litwin, Qing Zhang, Ioannis Tsialtas +10
    Nature CommunicationsPeer-reviewedCC BY-NC-NDFull text5 citedPhysiologyOpenAlex
  5. Circadian rhythm dysregulation and ferroptosis in hypertension: mechanisms and therapeutic implications
    Hui Zeng, Jiawen Lin, Jun Chen
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textPhysiologyCrossrefEurope PMCPMC
BibTeX
@article{miyake2026intracrine,
  title = {{Intracrine androgen metabolism in the meibomian gland: regulation, circadian control, and implications in dry eye disease}},
  author = {Takahito Miyake and Masao Doi},
  journal = {Endocrine Journal},
  year = {2026},
  month = sep,
  doi = {10.1507/endocrj.ej26-0148},
  url = {https://www.jstage.jst.go.jp/article/endocrj/73/9/73_EJ26-0148/_article},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Intracrine androgen metabolism in the meibomian gland: regulation, circadian control, and implications in dry eye disease
AU  - Takahito Miyake
AU  - Masao Doi
PY  - 2026
DA  - 2026/09/01
JO  - Endocrine Journal
DO  - 10.1507/endocrj.ej26-0148
UR  - https://www.jstage.jst.go.jp/article/endocrj/73/9/73_EJ26-0148/_article
AB  - The meibomian glands play a central role in maintaining ocular surface homeostasis by producing meibum, which is the lipid layer of the tear film that suppresses tear evaporation. Dysregulation of the secretion of this lipid leads to meibomian gland dysfunction (MGD), the most common cause of evaporative dry eye disease. Accumulating evidence indicates that androgen signaling is a critical regulator of meibomian gland structure and function. In contrast to classical endocrine mechanisms, androgen action in this tissue is largely mediated by intracrine steroid metabolism, whereby circulating adrenal precursors are locally converted to active androgens within the gland. Key steroidogenic enzymes, including 3β-hydroxysteroid dehydrogenase (3β-HSD), are expressed in the meibomian acinar cells, thereby enabling local testosterone production. Simultaneously, the gland exhibits robust metabolic pathways that convert testosterone to downstream androstane derivatives, providing a mechanism for the spatially restricted control of androgen signaling. Recent study has revealed that the intracrine steroidogenic system is affected by circadian rhythms. In particular, 3β-HSD activity exhibits daily rhythmicity that parallels fluctuations in nicotinamide adenine dinucleotide (NAD+), suggesting that NAD+-dependent metabolic processes contribute to temporal control of local androgen production. Importantly, administration of NAD+ precursors improves meibomian gland morphology in experimental models of aging-associated MGD. This review summarizes the current knowledge on intracrine androgen metabolism in the meibomian gland and highlights emerging metabolic and circadian mechanisms that may provide novel therapeutic targets for dry eye disease.
SN  - 1348-4540
SN  - 0918-8959
ER  -